White label – Pompe disease - ClinicalTrials.eu

Study on Retinoblastoma Treatment Using Etoposide, Carboplatin, and Melphalan for Patients with Specific Eye Conditions

Recruiting

2 1 1 1
Investigated Diseases:
- Retinoblastoma
Investigated Drugs:
Study on Pravastatin for Patients with Severe Radio-Induced Breast Fibrosis After Breast Cancer

Recruiting

2 1 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
- Pravastatin Sodium
Study on A49, A52, and Litenimod Sodium for Patients with Glioblastoma

Recruiting

2 1 1
Investigated Diseases:
- Glioblastoma
Investigated Drugs:
- A49
- A52
- Litenimod Sodium
Study of Autologous Microfat and Platelet-Rich Plasma Injection Compared to Wrist Denervation in Patients with Radiocarpal Osteoarthritis

Recruiting

2 1 1
Investigated Diseases:
- Osteoarthritis
Investigated Drugs:
- Autologous Microfat
- Platelet Concentrate
Study on AZD0901 and Drug Combination for Patients with Advanced Gastric, Gastroesophageal, and Pancreatic Cancers Expressing Claudin 18.2

Recruiting

1 1 1 1
Investigated Diseases:
Investigated Drugs:
Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

Recruiting

3 1 1
Investigated Diseases:
- Duchenne muscular dystrophy
Investigated Drugs:
- Givinostat
Study on the Effectiveness of Sphenopalatine Ganglion Block vs. Scalp Block in Patients Undergoing Craniotomy for Supratentorial Mass Using Levobupivacaine and Drug Combination

Recruiting

3 1 1
Investigated Drugs:
Study of zongertinib tablets in patients with advanced solid tumors that have HER2 gene changes

Recruiting

2 1 1
Investigated Drugs:
- Zongertinib
+1
Study on Reducing HIV Latent Reservoirs Using High Doses of Lamivudine, Maraviroc, and Dolutegravir Sodium for Patients with HIV Infection

Recruiting

2 1 1 1
Investigated Diseases:
- HIV infection
Investigated Drugs:
Study of Trastuzumab Deruxtecan for Patients with Early Stage HER2-Positive Breast Cancer

Recruiting

4 1 1 1
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies